Pegvisomant

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

WikiDoc Resources for Pegvisomant
Articles
Most recent articles on Pegvisomant Most cited articles on Pegvisomant Review articles on Pegvisomant Articles on Pegvisomant in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pegvisomant Images of Pegvisomant Photos of Pegvisomant Podcasts & MP3s on Pegvisomant Videos on Pegvisomant
Evidence Based Medicine
Cochrane Collaboration on Pegvisomant Bandolier on Pegvisomant TRIP on Pegvisomant
Clinical Trials
Ongoing Trials on Pegvisomant at Clinical Trials.gov Trial results on Pegvisomant Clinical Trials on Pegvisomant at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pegvisomant NICE Guidance on Pegvisomant NHS PRODIGY Guidance FDA on Pegvisomant CDC on Pegvisomant
Books
Books on Pegvisomant
News
Pegvisomant in the news Be alerted to news on Pegvisomant News trends on Pegvisomant
Commentary
Blogs on Pegvisomant
Definitions
Definitions of Pegvisomant
Patient Resources / Community
Patient resources on Pegvisomant Discussion groups on Pegvisomant Patient Handouts on Pegvisomant Directions to Hospitals Treating Pegvisomant Risk calculators and risk factors for Pegvisomant
Healthcare Provider Resources
Symptoms of Pegvisomant Causes & Risk Factors for Pegvisomant Diagnostic studies for Pegvisomant Treatment of Pegvisomant
Continuing Medical Education (CME)
CME Programs on Pegvisomant
International
Pegvisomant en Espanol Pegvisomant en Francais
Business
Pegvisomant in the Marketplace Patents on Pegvisomant
Experimental / Informatics
List of terms related to Pegvisomant

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Pegvisomant is a growth hormone receptor antagonist commonly used in the treatment of acromegaly.

v • d • e Pituitary and hypothalamic hormones and analogues (H01)
Anterior pituitary	Adrenocorticotropic hormone (Corticotropin, Tetracosactide) - Thyrotropin - Somatropin/agonists (Somatrem, Mecasermin, Sermorelin) - other (Pegvisomant)
Posterior pituitary	Vasopressin (Desmopressin, Lypressin, Terlipressin, Ornipressin, Argipressin) - Oxytocin (Demoxytocin, Carbetocin)
Hypothalamic	gonadotropin-releasing hormones (Gonadorelin, Nafarelin, Histrelin) - antigrowth hormone (Somatostatin, Octreotide, Lanreotide) - anti-gonadotropin-releasing hormones (Ganirelix, Cetrorelix)

v • d • e WikiDoc Research Resources for Pegvisomant
Articles on Pegvisomant	Most recent articles on Pegvisomant • Most cited articles on Pegvisomant • Review articles on Pegvisomant • Articles on Pegvisomant in N Eng J Med, Lancet, BMJ
Media (Slides, Video, Images, MP3) on Pegvisomant	Powerpoint slides on Pegvisomant • Images of Pegvisomant • Photos of Pegvisomant • Podcasts & MP3s on Pegvisomant • Videos on Pegvisomant
Evidence Based Medicine Regarding Pegvisomant	Cochrane Collaboration on Pegvisomant • Bandolier on Pegvisomant • TRIP on Pegvisomant
Cost Effectiveness of Pegvisomant	Cost Effectiveness of Pegvisomant
Clinical Trials Involving Pegvisomant	Ongoing Trials on Pegvisomant at Clinical Trials.gov • Trial results on Pegvisomant • Clinical Trials on Pegvisomant at Google
Guidelines / Policies / Government Resources (FDA/CDC) Regarding Pegvisomant	US National Guidelines Clearinghouse on Pegvisomant • NICE Guidance on Pegvisomant • NHS PRODIGY Guidance • FDA on Pegvisomant • CDC on Pegvisomant
Textbook Information on Pegvisomant	Books and Textbook Information on Pegvisomant
Pharmacology Resources on Pegvisomant	Dosing of Pegvisomant • Drug interactions with Pegvisomant • Side effects of Pegvisomant • Allergic reactions to Pegvisomant • Overdose information on Pegvisomant • Carcinogenicity information on Pegvisomant • Pegvisomant in pregnancy • Pharmacokinetics of Pegvisomant •
Genetics, Pharmacogenomics, and Proteinomics of Pegvisomant	Genetics of Pegvisomant • Pharmacogenomics of Pegvisomant • Proteomics of Pegvisomant
Newstories on Pegvisomant	Pegvisomant in the news • Be alerted to news on Pegvisomant • News trends on Pegvisomant
Commentary on Pegvisomant	Blogs on Pegvisomant
Patient Resources on Pegvisomant	Patient resources on Pegvisomant • Discussion groups on Pegvisomant • Patient Handouts on Pegvisomant • Directions to Hospitals Treating Pegvisomant • Risk calculators and risk factors for Pegvisomant
Healthcare Provider Resources on Pegvisomant	Symptoms of Pegvisomant • Causes & Risk Factors for Pegvisomant • Diagnostic studies for Pegvisomant • Treatment of Pegvisomant
Continuing Medical Education (CME) Programs on Pegvisomant	CME Programs on Pegvisomant
International Resources on Pegvisomant	Pegvisomant en Espanol • Pegvisomant en Francais
Business Resources on Pegvisomant	Pegvisomant in the Marketplace • Patents on Pegvisomant
Informatics Resources on Pegvisomant	List of terms related to Pegvisomant